A61K 2300/00
Mixtures or combinations of active ingredients, wherein at least one active ingredient
Official title: Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
A61K2300/00 (Mixtures or combinations of active ingredients, wherein at least one active ingredient) appears on 2,157 US grants and 3,664 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,157
- Published applications
- 3,664
- Assignees
- 1,605
- Inventors
- 6,179
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 3 | 0 |
| 1999 | 8 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 3 | 9 |
| 2005 | 1 | 9 |
| 2006 | 1 | 10 |
| 2007 | 3 | 19 |
| 2008 | 1 | 27 |
| 2009 | 3 | 36 |
| 2010 | 4 | 47 |
| 2011 | 13 | 71 |
| 2012 | 24 | 101 |
| 2013 | 41 | 77 |
| 2014 | 93 | 145 |
| 2015 | 100 | 117 |
| 2016 | 95 | 143 |
| 2017 | 150 | 269 |
| 2018 | 146 | 883 |
| 2019 | 274 | 423 |
| 2020 | 349 | 298 |
| 2021 | 238 | 229 |
| 2022 | 161 | 191 |
| 2023 | 118 | 139 |
| 2024 | 114 | 168 |
| 2025 | 98 | 147 |
| 2026 | 90 | 103 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Methods of treating Prader Willi Syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener29 Sep 2026US 12,746,244 B2Sedogen LLC
- Essential oil compositions and applications utilizing essential oils29 Sep 2026US 12,746,266 B2Ralco Nutrition, Inc.
- Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations29 Sep 2026US 12,746,268 B2Nymox Corporation
- N2-arylmethyl-4-haloalkyl-pyridazin-3-one CFTR modulators for the treatment of cystic fibrosis29 Sep 2026US 12,747,215 B2Centre National de la Recherche Scientifique (CNRS)
- Plant-based amyloid fibrils, their Preparation Method, Composite Film, and Composite Coating Preservative1 Oct 2026US 2026/0294998 A1Zhejiang University
- Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin24 Sep 2026US 2026/0284054 A1Ipsen Biopharm Ltd.
- Contraceptive compositions and methods for improved efficacy and modulation of side effects24 Sep 2026US 2026/0284077 A1Agile Therapeutics, Inc.
- Collagen peptide-based medicament compositions and devices and methods of production and use thereof17 Sep 2026US 2026/0273015 A1Sustain Holdings, LLC
- Oral biodelivery platform17 Sep 2026US 2026/0273079 A1BioDrive, Inc.
Most cited
By later US patents
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009
- Methods and compositions for improving digestion and absorption in the small intestine216US 5,977,175 ACedars-Sinai Medical Center · 1999
- Inhibitors of brutons tyrosine kinase159US 8,088,781 B2Pharmacyclics, Inc. · 2012
- Methods of reducing the risk of a cardiovascular event in a subject on statin therapy148US 9,610,272 B2Amarin Pharmaceuticals Ireland Limited · 2017